Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Revenue (2017 - 2025)

Catheter Precision (VTAK) has disclosed Revenue for 8 consecutive years, with $226000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Revenue rose 135.42% to $226000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $730000.0, a 82.96% increase, with the full-year FY2024 number at $420000.0, down 4.98% from a year prior.
  • Revenue was $226000.0 for Q3 2025 at Catheter Precision, up from $212000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.0 million in Q2 2021 to a low of -$992000.0 in Q4 2021.
  • A 5-year average of $87000.0 and a median of $96000.0 in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: crashed 99.71% in 2021, then surged 1820.0% in 2023.
  • Catheter Precision's Revenue stood at -$992000.0 in 2021, then soared by 100.5% to $5000.0 in 2022, then soared by 2460.0% to $128000.0 in 2023, then increased by 16.41% to $149000.0 in 2024, then soared by 51.68% to $226000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Revenue are $226000.0 (Q3 2025), $212000.0 (Q2 2025), and $143000.0 (Q1 2025).